Status:
UNKNOWN
Culture System for Isolating Circulating Tumor Cells
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Early Detection of Cancer
Eligibility:
All Genders
20-70 years
Brief Summary
This culture system utilizes the special affinity difference of biomedical material coating for different cells to achieve the effect of isolating cancer cells from the blood sample. The coating of th...
Eligibility Criteria
Inclusion
- Polycythemia patients are between the ages of 20 and 70.
- Willing to sign the consent form under the informed consent.
Exclusion
- 1\. Vulnerable Subjects included minors, prisoners, aborigines, pregnant women, people with mental disorders, students, and subordinates, etc.
Key Trial Info
Start Date :
January 29 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 26 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03843450
Start Date
January 29 2019
End Date
September 26 2022
Last Update
November 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan